The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1494
May 9, 2016
View Complete Issue         Table of Contents 2019 
BioThrax and Anthrasil for Anthrax
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
BioThrax and Anthrasil for Anthrax
May 9, 2016 (Issue: 1494)
The FDA has approved anthrax vaccine adsorbed (AVA; BioThrax – Emergent BioSolutions) for prevention of anthrax disease in adults following exposure to Bacillus anthracis and intravenous anthrax immune globulin (Anthrasil – Emergent...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: BioThrax and Anthrasil for Anthrax
Article code: 1494d
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.